Polistena, B, F Spandonaro, R Capra, S Fantaccini, L Santoni, GB Zimatore, and C Gasperini. “The Societal Impact of Treatment With Natalizumab of Relapsing–remitting Multiple Sclerosis in Italian Clinical Practice: The Tysabri® PharmacoEconomics (TyPE) Study”. Global & Regional Health Technology Assessment 6, no. 1 (June 12, 2019). Accessed April 2, 2020. https://journals.aboutscience.eu/index.php/grhta/article/view/463.